BOT 1.43% 34.5¢ botanix pharmaceuticals ltd

Looking Forward to a GREAT 2020, page-415

  1. 930 Posts.
    lightbulb Created with Sketch. 111
    The same team that designed the BTX1503 Phase II trial designed the Phase II eczema trial so I definitely think that we need to wary and not take success as a given
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.